Medtech Insight's 'Investment In Innovation' Conference Highlights Emerging Medical Technologies

Apr 16, 2001, 01:00 ET from Medtech Insight

    WASHINGTON, April 16 /PRNewswire/ -- Medtech Insight, a well-known
 provider of business information on new technologies and emerging companies in
 the medical industry, will be hosting a two-day conference, "Investment In
 Innovation: A Preview of Early Stage Medical Technologies" at Boston's Hyatt
 Harborside Hotel, June 14-15, 2001. More than 50 mostly privately held medical
 technology companies will give presentations over the course of two days.
 Following each company's presentation, break-out rooms will be available for
 individual meetings with interested parties.  Invited companies will present
 on a range of emerging medical technologies, including stroke management,
 spine surgery, gene and cell therapy, remote monitoring to wireless
 diagnostics and use of the internet.  Confirmed presenters to date include:
 
     *  Accuray Oncology -- stereotactic radiosurgery/radiotherapy for
        treatment of solid cancers
 
     *  A-Med Systems, Inc. -- circulatory support for cardiac surgery and
        interventions
 
     *  American OsteoMedix -- controlled delivery for osteoplasty
 
     *  Atherotech -- lipid panel for substantially improving the
        identification of cardiovascular disease risk
 
     *  Bacchus Vascular Inc. -- alternative techniques and devices for
        percutaneous venous and arterial thrombectomy
 
     *  BioHeart, Inc. -- genotyping for heart muscle regeneration
 
     *  Boston Medical Technologies, Inc. -- non-invasive method for testing
        heart rate variability
 
     *  Cardio-optics Inc. -- visualization technology to enable real-time
        imaging of tissues normally obscured by blood
 
     *  Converge Medical -- anastomotic coupling technology
 
     *  Cortek, Inc. -- lumbar and cervical spinal fusion technologies
 
     *  Cryovascular Systems, Inc. -- catheter system to prevent post
        angioplasty/stent placement coronary artery restenosis
 
     *  Endologix -- minimally invasive stent technology for abdominal aortic
        aneurysm
 
     *  FireLogic, Inc. -- wireless applications for accelerating clinical
        trials and managing treatment outcomes
 
     *  First Circle Medical -- novel platform for treatment of Hepatitis C
 
     *  Hamilton Thorne Biosciences -- reproductive cell analysis systems
 
     *  IDev Technologies, Inc. -- minimally invasive interventional
        radiology/vascular surgery technologies
 
     *  ImPres Medical, Inc. -- platform technology for management of
        gynecologic disorders, including abnormal uterine bleeding
 
     *  Medical Simulation Corporation -- technology for interactive training
        of healthcare professionals in state-of-the-art medical procedures
 
     *  MedLink Europe -- medical device supply chain management
 
     *  Metasensors, Inc. -- diagnostic/monitoring products based on gas
        flowing in microfluidic elements
 
     *  MicroCHIPS, Inc. -- silicon microchip delivered chemical & drug
        delivery devices
 
     *  Nervation Ltd. -- polyurethane-based vascular graft devices for the
        treatment of late-stage cardiovascular disease
 
     *  Odin Medical Technologies -- intraoperative MRI systems for
        neurosurgery
 
     *  Replication Medical -- spinal nucleus replacement device
 
     *  Sensatex/LifeLink -- "SmartShirt"-a wireless device for remote
        monitoring
 
     *  Spectrasonics Imaging, Inc. -- high intensity focused ultrasound (HIFU)
        therapy and tissue parameter imaging
 
     *  Spine Solutions -- total disc replacement prosthesis
 
     *  Spine-issimus Ltd. -- thermal treatment of back and arthritis pain
 
     *  SuturTek Incorporated -- mechanical suturing technology and devices for
        minimally invasive surgery
 
     *  Tensegra, Inc. -- artificial disc replacement
 
     *  The Spineology Group -- new techniques and devices for osteogenesis
 
     *  Tissue Transformation Technologies -- cell-based in vitro models for
        research, drug metabolism, toxicity and compound screening
 
     *  TissueLink Medical, Inc. -- hemostasis and anastomosis device
 
     *  VenPro Corporation -- surgical and percutaneous management of chronic
        venous insufficiency
 
     *  VSM MedTech Ltd. -- devices for improved vital signs monitoring
 
     *  X-Site Medical, LLC -- arteriotomy closure system
 
     "These innovative companies are at the forefront of the market for
 emerging medical technologies," reports Sharon O'Reilly, President of Medtech
 Insight. "Our forum will provide an excellent venue for introduction of these
 innovators to the investment community, established medtech companies seeking
 partnership, and other market players."
     The "Investment In Innovation" (IN3) conference, which is co-sponsored by
 Arthur Anderson Corporate Finance, Prism Venture Partners, Advanced Technology
 Ventures, Battelle Memorial Institute, MEDMARC, The Patterson Group, ZEVEX,
 and The MedTech Group, is designed for senior executives from the medical
 device and biotech industry, investment bankers and venture capitalists to
 gain exposure to early stage medical technology companies for the purpose of
 investment, acquisition and/or strategic partnering. On-demand viewing of
 company presentations from Medtech Insight's January 2001 "Investment In
 Innovation" conference can be purchased and accessed through the Medtech
 Insight website, at http://www.medtechinsight.com .
 
     Medtech Insight is the publisher of "Medtech Insight" (formerly
 "BioMaterials & Surgery"), a monthly newsletter designed to keep medical
 device executives up-to-date on the latest discoveries, trends and innovations
 in the medical device industry. The company also publishes analyses of medical
 technology markets through its Reports group, and provides utilization
 database and other content for the medical technology marketplace. For more
 information on Medtech Insight, please contact Scott Pantel at 714-969-7648 or
 by email at scott@medtechinsight.com, or visit us on the web at
 http://www.medtechinsight.com .  Details on the upcoming IN3 conference in
 Boston are available at http://www.medtechinsight.com/in3-02.html .
 
 

SOURCE Medtech Insight
    WASHINGTON, April 16 /PRNewswire/ -- Medtech Insight, a well-known
 provider of business information on new technologies and emerging companies in
 the medical industry, will be hosting a two-day conference, "Investment In
 Innovation: A Preview of Early Stage Medical Technologies" at Boston's Hyatt
 Harborside Hotel, June 14-15, 2001. More than 50 mostly privately held medical
 technology companies will give presentations over the course of two days.
 Following each company's presentation, break-out rooms will be available for
 individual meetings with interested parties.  Invited companies will present
 on a range of emerging medical technologies, including stroke management,
 spine surgery, gene and cell therapy, remote monitoring to wireless
 diagnostics and use of the internet.  Confirmed presenters to date include:
 
     *  Accuray Oncology -- stereotactic radiosurgery/radiotherapy for
        treatment of solid cancers
 
     *  A-Med Systems, Inc. -- circulatory support for cardiac surgery and
        interventions
 
     *  American OsteoMedix -- controlled delivery for osteoplasty
 
     *  Atherotech -- lipid panel for substantially improving the
        identification of cardiovascular disease risk
 
     *  Bacchus Vascular Inc. -- alternative techniques and devices for
        percutaneous venous and arterial thrombectomy
 
     *  BioHeart, Inc. -- genotyping for heart muscle regeneration
 
     *  Boston Medical Technologies, Inc. -- non-invasive method for testing
        heart rate variability
 
     *  Cardio-optics Inc. -- visualization technology to enable real-time
        imaging of tissues normally obscured by blood
 
     *  Converge Medical -- anastomotic coupling technology
 
     *  Cortek, Inc. -- lumbar and cervical spinal fusion technologies
 
     *  Cryovascular Systems, Inc. -- catheter system to prevent post
        angioplasty/stent placement coronary artery restenosis
 
     *  Endologix -- minimally invasive stent technology for abdominal aortic
        aneurysm
 
     *  FireLogic, Inc. -- wireless applications for accelerating clinical
        trials and managing treatment outcomes
 
     *  First Circle Medical -- novel platform for treatment of Hepatitis C
 
     *  Hamilton Thorne Biosciences -- reproductive cell analysis systems
 
     *  IDev Technologies, Inc. -- minimally invasive interventional
        radiology/vascular surgery technologies
 
     *  ImPres Medical, Inc. -- platform technology for management of
        gynecologic disorders, including abnormal uterine bleeding
 
     *  Medical Simulation Corporation -- technology for interactive training
        of healthcare professionals in state-of-the-art medical procedures
 
     *  MedLink Europe -- medical device supply chain management
 
     *  Metasensors, Inc. -- diagnostic/monitoring products based on gas
        flowing in microfluidic elements
 
     *  MicroCHIPS, Inc. -- silicon microchip delivered chemical & drug
        delivery devices
 
     *  Nervation Ltd. -- polyurethane-based vascular graft devices for the
        treatment of late-stage cardiovascular disease
 
     *  Odin Medical Technologies -- intraoperative MRI systems for
        neurosurgery
 
     *  Replication Medical -- spinal nucleus replacement device
 
     *  Sensatex/LifeLink -- "SmartShirt"-a wireless device for remote
        monitoring
 
     *  Spectrasonics Imaging, Inc. -- high intensity focused ultrasound (HIFU)
        therapy and tissue parameter imaging
 
     *  Spine Solutions -- total disc replacement prosthesis
 
     *  Spine-issimus Ltd. -- thermal treatment of back and arthritis pain
 
     *  SuturTek Incorporated -- mechanical suturing technology and devices for
        minimally invasive surgery
 
     *  Tensegra, Inc. -- artificial disc replacement
 
     *  The Spineology Group -- new techniques and devices for osteogenesis
 
     *  Tissue Transformation Technologies -- cell-based in vitro models for
        research, drug metabolism, toxicity and compound screening
 
     *  TissueLink Medical, Inc. -- hemostasis and anastomosis device
 
     *  VenPro Corporation -- surgical and percutaneous management of chronic
        venous insufficiency
 
     *  VSM MedTech Ltd. -- devices for improved vital signs monitoring
 
     *  X-Site Medical, LLC -- arteriotomy closure system
 
     "These innovative companies are at the forefront of the market for
 emerging medical technologies," reports Sharon O'Reilly, President of Medtech
 Insight. "Our forum will provide an excellent venue for introduction of these
 innovators to the investment community, established medtech companies seeking
 partnership, and other market players."
     The "Investment In Innovation" (IN3) conference, which is co-sponsored by
 Arthur Anderson Corporate Finance, Prism Venture Partners, Advanced Technology
 Ventures, Battelle Memorial Institute, MEDMARC, The Patterson Group, ZEVEX,
 and The MedTech Group, is designed for senior executives from the medical
 device and biotech industry, investment bankers and venture capitalists to
 gain exposure to early stage medical technology companies for the purpose of
 investment, acquisition and/or strategic partnering. On-demand viewing of
 company presentations from Medtech Insight's January 2001 "Investment In
 Innovation" conference can be purchased and accessed through the Medtech
 Insight website, at http://www.medtechinsight.com .
 
     Medtech Insight is the publisher of "Medtech Insight" (formerly
 "BioMaterials & Surgery"), a monthly newsletter designed to keep medical
 device executives up-to-date on the latest discoveries, trends and innovations
 in the medical device industry. The company also publishes analyses of medical
 technology markets through its Reports group, and provides utilization
 database and other content for the medical technology marketplace. For more
 information on Medtech Insight, please contact Scott Pantel at 714-969-7648 or
 by email at scott@medtechinsight.com, or visit us on the web at
 http://www.medtechinsight.com .  Details on the upcoming IN3 conference in
 Boston are available at http://www.medtechinsight.com/in3-02.html .
 
 SOURCE  Medtech Insight